Biocon has informed that a meeting of the board of directors of the company will be held on July 25, 2012, to approve and take on record the unaudited financial results of the company for the quarter ended on June 30, 2012 and the merger of Biocon Biopharmaceuticals Limited; a wholly owned subsidiary with the company.
The above information is a part of company's filings submitted to BSE.